Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Potential Immunotherapeutics for Immunosuppression in Sepsis

  • Shin, Jinwook (Department of Microbiology, College of Medicine, Inha University) ;
  • Jin, Mirim (2 Department of Microbiology, College of Medicine, Gachon University)
  • Received : 2017.09.26
  • Accepted : 2017.10.10
  • Published : 2017.11.01
Download PDF
⟨ Previous Next ⟩

Abstract

Sepsis is a syndrome characterized by systemic inflammatory responses to a severe infection. Acute hyper-inflammatory reactions in the acute phase of sepsis have been considered as a primary reason for organ dysfunction and mortality, and advances in emergency intervention and improved intensive care management have reduced mortalities in the early phase. However it has been recognized that increased deaths in the late phase still maintain sepsis mortality high worldwide. Patients recovered from early severe illness are unable to control immune system with sepsis-induced immunosuppression such as immunological tolerance, exhaustion and apoptosis, which make them vulnerable to nosocomial and opportunistic infections ultimately leading to threat to life. Based on strategies to reverse immunosuppression, recent developments in sepsis therapy are focused on molecules having immune enhancing activities. These efforts are focused on defining and revising the immunocompromised status associated with long-term mortality.

Keywords

References

  1. Alves-Filho, J. C., Freitas, A., Souto, F. O., Spiller, F., Paula-Neto, H., Silva, J. S., Gazzinelli, R. T., Teixeira, M. M., Ferreira, S. H. and Cunha, F. Q. (2009) Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc. Natl. Acad. Sci. U.S.A. 106, 4018-4023. https://doi.org/10.1073/pnas.0900196106
  2. Alves-Filho, J. C., Spiller, F. and Cunha, F. Q. (2010) Neutrophil paralysis in sepsis. Shock 34 Suppl 1, 15-21. https://doi.org/10.1097/SHK.0b013e3181e7e61b
  3. Angus, D. C. (2012) Drotrecogin alfa (activated)...a sad final fizzle to a roller-coaster party. Crit Care 16, 107. https://doi.org/10.1186/cc11152
  4. Benjamim, C. F., Lundy, S. K., Lukacs, N. W., Hogaboam, C. M. and Kunkel, S. L. (2005) Reversal of long-term sepsis-induced immunosuppression by dendritic cells. Blood 105, 3588-3595. https://doi.org/10.1182/blood-2004-08-3251
  5. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. and Kuchroo, V. K. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238. https://doi.org/10.1038/nature04753
  6. Biedermann, T., Kneilling, M., Mailhammer, R., Maier, K., Sander, C. A., Kollias, G., Kunkel, S. L., Hultner, L. and Rocken, M. (2000) Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192, 1441-1452. https://doi.org/10.1084/jem.192.10.1441
  7. Biswas, S. K. and Lopez-Collazo, E. (2009) Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30, 475-487. https://doi.org/10.1016/j.it.2009.07.009
  8. Bo, L., Wang, F., Zhu, J., Li, J. and Deng, X. (2011) Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Crit. Care 15, R58. https://doi.org/10.1186/cc10031
  9. Boomer, J. S., To, K., Chang, K. C., Takasu, O., Osborne, D. F., Walton, A. H., Bricker, T. L., Jarman, S. D., 2nd, Kreisel, D., Krupnick, A. S., Srivastava, A., Swanson, P. E., Green, J. M. and Hotchkiss, R. S. (2011) Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306, 2594-2605. https://doi.org/10.1001/jama.2011.1829
  10. Camacho-Gonzalez, A., Spearman, P. W. and Stoll, B. J. (2013) Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr. Clin. North Am. 60, 367-389. https://doi.org/10.1016/j.pcl.2012.12.003
  11. Cavaillon, J. M. and Adib-Conquy, M. (2006) Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit. Care 10, 233. https://doi.org/10.1186/cc5055
  12. Chang, K., Svabek, C., Vazquez-Guillamet, C., Sato, B., Rasche, D., Wilson, S., Robbins, P., Ulbrandt, N., Suzich, J., Green, J., Patera, A. C., Blair, W., Krishnan, S. and Hotchkiss, R. (2014) Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit. Care 18, R3. https://doi.org/10.1186/cc13176
  13. Chang, K. C., Burnham, C. A., Compton, S. M., Rasche, D. P., Mazuski, R. J., McDonough, J. S., Unsinger, J., Korman, A. J., Green, J. M. and Hotchkiss, R. S. (2013) Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis. Crit. Care 17, R85. https://doi.org/10.1186/cc12711
  14. Chen, L. and Flies, D. B. (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 13, 227-242. https://doi.org/10.1038/nri3405
  15. Coopersmith, C. M., Wunsch, H., Fink, M. P., Linde-Zwirble, W. T., Olsen, K. M., Sommers, M. S., Anand, K. J., Tchorz, K. M., Angus, D. C. and Deutschman, C. S. (2012) A comparison of critical care research funding and the financial burden of critical illness in the United States. Crit. Care Med. 40, 1072-1079. https://doi.org/10.1097/CCM.0b013e31823c8d03
  16. Cummings, C. J., Martin, T. R., Frevert, C. W., Quan, J. M., Wong, V. A., Mongovin, S. M., Hagen, T. R., Steinberg, K. P. and Goodman, R. B. (1999) Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J. Immunol. 162, 2341-2346.
  17. Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., Mncube, Z., Duraiswamy, J., Zhu, B., Eichbaum, Q., Altfeld, M., Wherry, E. J., Coovadia, H. M., Goulder, P. J., Klenerman, P., Ahmed, R., Freeman, G. J. and Walker, B. D. (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350-354. https://doi.org/10.1038/nature05115
  18. Delano, M. J., Thayer, T., Gabrilovich, S., Kelly-Scumpia, K. M., Winfield, R. D., Scumpia, P. O., Cuenca, A. G., Warner, E., Wallet, S. M., Wallet, M. A., O'Malley, K. A., Ramphal, R., Clare-Salzer, M., Efron, P. A., Mathews, C. E. and Moldawer, L. L. (2011) Sepsis induces early alterations in innate immunity that impact mortality to secondary infection. J. Immunol. 186, 195-202. https://doi.org/10.4049/jimmunol.1002104
  19. Delano, M. J. and Ward, P. A. (2016) Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J. Clin. Invest. 126, 23-31. https://doi.org/10.1172/JCI82224
  20. Docke, W. D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H. D. and Kox, W. (1997) Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat. Med. 3, 678-681. https://doi.org/10.1038/nm0697-678
  21. Dries, D. J., Jurkovich, G. J., Maier, R. V., Clemmer, T. P., Struve, S. N., Weigelt, J. A., Stanford, G. G., Herr, D. L., Champion, H. R., Lewis, F. R., Hoyt, D., Hansbrough, J., Yellin, A. E., Berne, T. V., Trunkey, D. D., Jaffe, H. S., Munera, C., Fisher, P. and Starko, K. M. (1994) Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial. Arch. Surg. 129, 1031-1041; discussion 1042. https://doi.org/10.1001/archsurg.1994.01420340045008
  22. Ertel, W., Kremer, J. P., Kenney, J., Steckholzer, U., Jarrar, D., Trentz, O. and Schildberg, F. W. (1995) Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85, 1341-1347.
  23. Fehervari, Z. and Sakaguchi, S. (2004) CD4+ Tregs and immune control. J. Clin. Invest. 114, 1209-1217. https://doi.org/10.1172/JCI200423395
  24. Felmet, K. A., Hall, M. W., Clark, R. S., Jaffe, R. and Carcillo, J. A. (2005) Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J. Immunol. 174, 3765-3772. https://doi.org/10.4049/jimmunol.174.6.3765
  25. Fink, M. P. and Warren, H. S. (2014) Strategies to improve drug development for sepsis. Nat. Rev. Drug Discov. 13, 741-758. https://doi.org/10.1038/nrd4368
  26. Francisco-Cruz, A., Aguilar-Santelises, M., Ramos-Espinosa, O., Mata-Espinosa, D., Marquina-Castillo, B., Barrios-Payan, J. and Hernandez-Pando, R. (2014) Granulocyte-macrophage colony-stimulating factor: not just another haematopoietic growth factor. Med. Oncol. 31, 774. https://doi.org/10.1007/s12032-013-0774-6
  27. Gaieski, D. F., Edwards, J. M., Kallan, M. J. and Carr, B. G. (2013) Benchmarking the incidence and mortality of severe sepsis in the United States. Crit. Care Med. 41, 1167-1174. https://doi.org/10.1097/CCM.0b013e31827c09f8
  28. Gautier, E. L., Huby, T., Saint-Charles, F., Ouzilleau, B., Chapman, M. J. and Lesnik, P. (2008) Enhanced dendritic cell survival attenuates lipopolysaccharide-induced immunosuppression and increases resistance to lethal endotoxic shock. J. Immunol. 180, 6941-6946. https://doi.org/10.4049/jimmunol.180.10.6941
  29. Gow, N. A., van de Veerdonk, F. L., Brown, A. J. and Netea, M. G. (2011) Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat. Rev. Microbiol. 10, 112-122.
  30. Guignant, C., Lepape, A., Huang, X., Kherouf, H., Denis, L., Poitevin, F., Malcus, C., Cheron, A., Allaouchiche, B., Gueyffier, F., Ayala, A., Monneret, G. and Venet, F. (2011) Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit. Care 15, R99. https://doi.org/10.1186/cc10112
  31. Guisset, O., Dilhuydy, M. S., Thiebaut, R., Lefevre, J., Camou, F., Sarrat, A., Gabinski, C., Moreau, J. F. and Blanco, P. (2007) Decrease in circulating dendritic cells predicts fatal outcome in septic shock. Intensive Care Med. 33, 148-152. https://doi.org/10.1007/s00134-006-0436-7
  32. Hall, M. W., Knatz, N. L., Vetterly, C., Tomarello, S., Wewers, M. D., Volk, H. D. and Carcillo, J. A. (2011) Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med. 37, 525-532. https://doi.org/10.1007/s00134-010-2088-x
  33. Heffernan, D. S., Monaghan, S. F., Thakkar, R. K., Machan, J. T., Cioffi, W. G. and Ayala, A. (2012) Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern. Crit Care 16, R12. https://doi.org/10.1186/cc11157
  34. Heidecke, C. D., Hensler, T., Weighardt, H., Zantl, N., Wagner, H., Siewert, J. R. and Holzmann, B. (1999) Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am. J. Surg. 178, 288-292. https://doi.org/10.1016/S0002-9610(99)00183-X
  35. Hoeller, C., Michielin, O., Ascierto, P. A., Szabo, Z. and Blank, C. U. (2016) Systematic review of the use of granulocyte-macrophage colony-stimulating factor in patients with advanced melanoma. Cancer Immunol. Immunother. 65, 1015-1034. https://doi.org/10.1007/s00262-016-1860-3
  36. Hotchkiss, R. S., Monneret, G. and Payen, D. (2013a) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect. Dis. 13, 260-268. https://doi.org/10.1016/S1473-3099(13)70001-X
  37. Hotchkiss, R. S., Monneret, G. and Payen, D. (2013b) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13, 862-874. https://doi.org/10.1038/nri3552
  38. Hotchkiss, R. S. and Nicholson, D. W. (2006) Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6, 813-822. https://doi.org/10.1038/nri1943
  39. Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Grayson, M. H., Osborne, D. F., Wagner, T. H., Cobb, J. P., Coopersmith, C. and Karl, I. E. (2002) Depletion of dendritic cells, but not macrophages, in patients with sepsis. J. Immunol. 168, 2493-2500. https://doi.org/10.4049/jimmunol.168.5.2493
  40. Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Schmieg, R. E., Jr., Hui, J. J., Chang, K. C., Osborne, D. F., Freeman, B. D., Cobb, J. P., Buchman, T. G. and Karl, I. E. (2001) Sepsis-induced apoptosis causes progressive profound depletion of B and $CD4^+$ T lymphocytes in humans. J. Immunol. 166, 6952-6963. https://doi.org/10.4049/jimmunol.166.11.6952
  41. Huang, X., Chen, Y., Chung, C. S., Yuan, Z., Monaghan, S. F., Wang, F. and Ayala, A. (2014) Identification of B7-H1 as a novel mediator of the innate immune/pro-inflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis. J. Immunol. 192, 1091-1099. https://doi.org/10.4049/jimmunol.1302252
  42. Huang, X., Venet, F., Wang, Y. L., Lepape, A., Yuan, Z., Chen, Y., Swan, R., Kherouf, H., Monneret, G., Chung, C. S. and Ayala, A. (2009) PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc. Natl. Acad. Sci. U.S.A. 106, 6303-6308. https://doi.org/10.1073/pnas.0809422106
  43. Hutchins, N. A., Unsinger, J., Hotchkiss, R. S. and Ayala, A. (2014) The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol. Med. 20, 224-233. https://doi.org/10.1016/j.molmed.2014.01.002
  44. Kasten, K. R., Prakash, P. S., Unsinger, J., Goetzman, H. S., England, L. G., Cave, C. M., Seitz, A. P., Mazuski, C. N., Zhou, T. T., Morre, M., Hotchkiss, R. S., Hildeman, D. A. and Caldwell, C. C. (2010) Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through ${\gamma}{\delta}$ T-cell IL-17 production in a murine model of sepsis. Infect. Immun. 78, 4714-4722. https://doi.org/10.1128/IAI.00456-10
  45. Kaukonen, K. M., Bailey, M., Pilcher, D., Cooper, D. J. and Bellomo, R. (2015) Systemic inflammatory response syndrome criteria in defining severe sepsis. N. Engl. J. Med. 372, 1629-1638. https://doi.org/10.1056/NEJMoa1415236
  46. Kellum, J. A., Kong, L., Fink, M. P., Weissfeld, L. A., Yealy, D. M., Pinsky, M. R., Fine, J., Krichevsky, A., Delude, R. L. and Angus, D. C. (2007) Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch. Intern. Med. 167, 1655-1663. https://doi.org/10.1001/archinte.167.15.1655
  47. Kim, S. J., Park, J. S., Lee, D. W. and Lee, S. M. (2016) Trichostatin A protects liver against septic injury through inhibiting toll-like receptor signaling. Biomol. Ther. (Seoul) 24, 387-394. https://doi.org/10.4062/biomolther.2015.176
  48. Kollef, K. E., Schramm, G. E., Wills, A. R., Reichley, R. M., Micek, S. T. and Kollef, M. H. (2008) Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest 134, 281-287. https://doi.org/10.1378/chest.08-1116
  49. Kovach, M. A. and Standiford, T. J. (2012) The function of neutrophils in sepsis. Curr. Opin. Infect. Dis. 25, 321-327. https://doi.org/10.1097/QCO.0b013e3283528c9b
  50. Lerman, Y. V., Lim, K., Hyun, Y. M., Falkner, K. L., Yang, H., Pietropaoli, A. P., Sonnenberg, A., Sarangi, P. P. and Kim, M. (2014) Sepsis lethality via exacerbated tissue infiltration and TLR-induced cytokine production by neutrophils is integrin ${\alpha}3{\beta}1$-dependent. Blood 124, 3515-3523. https://doi.org/10.1182/blood-2014-01-552943
  51. Lewkowicz, P., Lewkowicz, N., Sasiak, A. and Tchorzewski, H. (2006) Lipopolysaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J. Immunol. 177, 7155-7163. https://doi.org/10.4049/jimmunol.177.10.7155
  52. Limaye, A. P., Kirby, K. A., Rubenfeld, G. D., Leisenring, W. M., Bulger, E. M., Neff, M. J., Gibran, N. S., Huang, M. L., Santo Hayes, T. K., Corey, L. and Boeckh, M. (2008) Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 300, 413-422. https://doi.org/10.1001/jama.300.4.413
  53. Liston, A. and Gray, D. H. (2014) Homeostatic control of regulatory T cell diversity. Nat. Rev. Immunol. 14, 154-165. https://doi.org/10.1038/nri3605
  54. Lorente, J. A. and Marshall, J. C. (2005) Neutralization of tumor necrosis factor in preclinical models of sepsis. Shock 24 Suppl 1, 107-119. https://doi.org/10.1097/01.shk.0000191343.21228.78
  55. Lukaszewicz, A. C., Grienay, M., Resche-Rigon, M., Pirracchio, R., Faivre, V., Boval, B. and Payen, D. (2009) Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit. Care Med. 37, 2746-2752.
  56. Lundstrom, W., Fewkes, N. M. and Mackall, C. L. (2012) IL-7 in human health and disease. Semin. Immunol. 24, 218-224. https://doi.org/10.1016/j.smim.2012.02.005
  57. Luyt, C. E. and Kaiser, L. (2012) Virus detection in patients with severe pneumonia: still more questions than answers? Am. J. Respir. Crit. Care Med. 186, 301-302. https://doi.org/10.1164/rccm.201206-1119ED
  58. Mackall, C. L., Fry, T. J. and Gress, R. E. (2011) Harnessing the biology of IL-7 for therapeutic application. Nat. Rev. Immunol. 11, 330-342. https://doi.org/10.1038/nri2970
  59. Mandai, M., Hamanishi, J., Abiko, K., Matsumura, N., Baba, T. and Konishi, I. (2016) Dual faces of $IFN{\gamma}$ in cancer progression: a role of PD-L1 induction in the determination of pro- and antitumor immunity. Clin. Cancer Res. 22, 2329-2334. https://doi.org/10.1158/1078-0432.CCR-16-0224
  60. Martin, G. S., Mannino, D. M., Eaton, S. and Moss, M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546-1554. https://doi.org/10.1056/NEJMoa022139
  61. Mayr, F. B., Yende, S. and Angus, D. C. (2014) Epidemiology of severe sepsis. Virulence 5, 4-11. https://doi.org/10.4161/viru.27372
  62. Meakins, J. L., Christou, N. V., Bohnen, J. and MacLean, L. D. (1982) Failure of delayed hypersensitivity skin testing to predict postoperative sepsis and mortality. Br. Med. J. (Clin. Res. Ed.) 285, 1207-1208.
  63. Meisel, C., Schefold, J. C., Pschowski, R., Baumann, T., Hetzger, K., Gregor, J., Weber-Carstens, S., Hasper, D., Keh, D., Zuckermann, H., Reinke, P. and Volk, H. D. (2009) Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am. J. Respir. Crit. Care Med. 180, 640-648. https://doi.org/10.1164/rccm.200903-0363OC
  64. Monneret, G., Debard, A. L., Venet, F., Bohe, J., Hequet, O., Bienvenu, J. and Lepape, A. (2003) Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit. Care Med. 31, 2068-2071. https://doi.org/10.1097/01.CCM.0000069345.78884.0F
  65. Monneret, G., Finck, M. E., Venet, F., Debard, A. L., Bohe, J., Bienvenu, J. and Lepape, A. (2004) The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol. Lett. 95, 193-198. https://doi.org/10.1016/j.imlet.2004.07.009
  66. Monneret, G., Venet, F., Kullberg, B. J. and Netea, M. G. (2011) ICU-acquired immunosuppression and the risk for secondary fungal infections. Med. Mycol. 49 Suppl 1, S17-S23. https://doi.org/10.3109/13693786.2010.509744
  67. Monneret, G., Venet, F., Pachot, A. and Lepape, A. (2008) Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol. Med. 14, 64-78.
  68. Moore, F. A. and Moore, E. E. (1995) Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg. Clin. North Am. 75, 257-277. https://doi.org/10.1016/S0039-6109(16)46587-4
  69. Morris, A. C., Brittan, M., Wilkinson, T. S., McAuley, D. F., Antonelli, J., McCulloch, C., Barr, L. C., McDonald, N. A., Dhaliwal, K., Jones, R. O., Mackellar, A., Haslett, C., Hay, A. W., Swann, D. G., Anderson, N., Laurenson, I. F., Davidson, D. J., Rossi, A. G., Walsh, T. S. and Simpson, A. J. (2011) C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patients. Blood 117, 5178-5188. https://doi.org/10.1182/blood-2010-08-304667
  70. Munford, R. S. and Pugin, J. (2001) Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am. J. Respir. Crit. Care Med. 163, 316-321. https://doi.org/10.1164/ajrccm.163.2.2007102
  71. Munoz, C., Carlet, J., Fitting, C., Misset, B., Bleriot, J. P. and Cavaillon, J. M. (1991) Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88, 1747-1754. https://doi.org/10.1172/JCI115493
  72. Nalos, M., Santner-Nanan, B., Parnell, G., Tang, B., McLean, A. S. and Nanan, R. (2012) Immune effects of interferon gamma in persistent staphylococcal sepsis. Am. J. Respir. Crit. Care Med. 185, 110-112. https://doi.org/10.1164/ajrccm.185.1.110
  73. Nathan, C. (2006) Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6, 173-182. https://doi.org/10.1038/nri1785
  74. Needham, D. M., Davidson, J., Cohen, H., Hopkins, R. O., Weinert, C., Wunsch, H., Zawistowski, C., Bemis-Dougherty, A., Berney, S. C., Bienvenu, O. J., Brady, S. L., Brodsky, M. B., Denehy, L., Elliott, D., Flatley, C., Harabin, A. L., Jones, C., Louis, D., Meltzer, W., Muldoon, S. R., Palmer, J. B., Perme, C., Robinson, M., Schmidt, D. M., Scruth, E., Spill, G. R., Storey, C. P., Render, M., Votto, J. and Harvey, M. A. (2012) Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference. Crit. Care Med. 40, 502-509. https://doi.org/10.1097/CCM.0b013e318232da75
  75. Nelson, S., Belknap, S. M., Carlson, R. W., Dale, D., DeBoisblanc, B., Farkas, S., Fotheringham, N., Ho, H., Marrie, T., Movahhed, H., Root, R. and Wilson, J. (1998) A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group. J. Infect. Dis. 178, 1075-1080.
  76. Otto, G. P., Sossdorf, M., Claus, R. A., Rodel, J., Menge, K., Reinhart, K., Bauer, M. and Riedemann, N. C. (2011) The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit. Care 15, R183. https://doi.org/10.1186/cc10332
  77. Pachot, A., Monneret, G., Voirin, N., Leissner, P., Venet, F., Bohe, J., Payen, D., Bienvenu, J., Mougin, B. and Lepape, A. (2005) Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock. Clin. Immunol. 114, 61-69. https://doi.org/10.1016/j.clim.2004.08.015
  78. Panacek, E. A., Marshall, J. C., Albertson, T. E., Johnson, D. H., Johnson, S., MacArthur, R. D., Miller, M., Barchuk, W. T., Fischkoff, S., Kaul, M., Teoh, L., Van Meter, L., Daum, L., Lemeshow, S., Hicklin, G. and Doig, C. (2004) Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit. Care Med. 32, 2173-2182. https://doi.org/10.1097/01.CCM.0000145229.59014.6C
  79. Parihar, A., Eubank, T. D. and Doseff, A. I. (2010) Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. J. Innate. Immun. 2, 204-215. https://doi.org/10.1159/000296507
  80. Pastille, E., Didovic, S., Brauckmann, D., Rani, M., Agrawal, H., Schade, F. U., Zhang, Y. and Flohe, S. B. (2011) Modulation of dendritic cell differentiation in the bone marrow mediates sustained immunosuppression after polymicrobial sepsis. J. Immunol. 186, 977-986. https://doi.org/10.4049/jimmunol.1001147
  81. Perales, M. A., Goldberg, J. D., Yuan, J., Koehne, G., Lechner, L., Papadopoulos, E. B., Young, J. W., Jakubowski, A. A., Zaidi, B., Gallardo, H., Liu, C., Rasalan, T., Wolchok, J. D., Croughs, T., Morre, M., Devlin, S. M. and van den Brink, M. R. (2012) Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. Blood 120, 4882-4891. https://doi.org/10.1182/blood-2012-06-437236
  82. Petit, I., Szyper-Kravitz, M., Nagler, A., Lahav, M., Peled, A., Habler, L., Ponomaryov, T., Taichman, R. S., Arenzana-Seisdedos, F., Fujii, N., Sandbank, J., Zipori, D. and Lapidot, T. (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3, 687-694. https://doi.org/10.1038/ni813
  83. Poehlmann, H., Schefold, J. C., Zuckermann-Becker, H., Volk, H. D. and Meisel, C. (2009) Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis. Crit. Care 13, R119. https://doi.org/10.1186/cc7969
  84. Qiu, P., Cui, X., Sun, J., Welsh, J., Natanson, C. and Eichacker, P. Q. (2013) Antitumor necrosis factor therapy is associated with improved survival in clinical sepsis trials: a meta-analysis. Crit. Care Med. 41, 2419-2429. https://doi.org/10.1097/CCM.0b013e3182982add
  85. Reber, A. J., Chirkova, T., Kim, J. H., Cao, W., Biber, R., Shay, D. K. and Sambhara, S. (2012). Immunosenescence and challenges of vaccination against influenza in the aging population. Aging Dis 3, 68-90.
  86. Riccardi, F., Della Porta, M. G., Rovati, B., Casazza, A., Radolovich, D., De Amici, M., Danova, M. and Langer, M. (2011) Flow cytometric analysis of peripheral blood dendritic cells in patients with severe sepsis. Cytometry B Clin. Cytom. 80, 14-21.
  87. Rice, T. W., Wheeler, A. P., Bernard, G. R., Vincent, J. L., Angus, D. C., Aikawa, N., Demeyer, I., Sainati, S., Amlot, N., Cao, C., Ii, M., Matsuda, H., Mouri, K. and Cohen, J. (2010) A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit. Care Med. 38, 1685-1694. https://doi.org/10.1097/CCM.0b013e3181e7c5c9
  88. Riewald, M. and Ruf, W. (2005) Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling. J. Biol. Chem. 280, 19808-19814. https://doi.org/10.1074/jbc.M500747200
  89. Romani, L. (2011) Immunity to fungal infections. Nat. Rev. Immunol. 11, 275-288. https://doi.org/10.1038/nri2939
  90. Ronchetti, S., Zollo, O., Bruscoli, S., Agostini, M., Bianchini, R., Nocentini, G., Ayroldi, E. and Riccardi, C. (2004) GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur. J. Immunol. 34, 613-622. https://doi.org/10.1002/eji.200324804
  91. Root, R. K., Lodato, R. F., Patrick, W., Cade, J. F., Fotheringham, N., Milwee, S., Vincent, J. L., Torres, A., Rello, J. and Nelson, S. (2003) Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis. Crit. Care Med. 31, 367-373. https://doi.org/10.1097/01.CCM.0000048629.32625.5D
  92. Roquilly, A., McWilliam, H. E. G., Jacqueline, C., Tian, Z., Cinotti, R., Rimbert, M., Wakim, L., Caminschi, I., Lahoud, M. H., Belz, G. T., Kallies, A., Mintern, J. D., Asehnoune, K. and Villadangos, J. A. (2017) Local modulation of antigen-presenting cell development after resolution of pneumonia induces long-term susceptibility to secondary infections. Immunity 47, 135-147.e5. https://doi.org/10.1016/j.immuni.2017.06.021
  93. Scumpia, P. O., Delano, M. J., Kelly-Scumpia, K. M., Weinstein, J. S., Wynn, J. L., Winfield, R. D., Xia, C., Chung, C. S., Ayala, A., Atkinson, M. A., Reeves, W. H., Clare-Salzler, M. J. and Moldawer, L. L. (2007) Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood 110, 3673-3681. https://doi.org/10.1182/blood-2007-04-087171
  94. Shalova, I. N., Lim, J. Y., Chittezhath, M., Zinkernagel, A. S., Beasley, F., Hernandez-Jimenez, E., Toledano, V., Cubillos-Zapata, C., Rapisarda, A., Chen, J., Duan, K., Yang, H., Poidinger, M., Melillo, G., Nizet, V., Arnalich, F., Lopez-Collazo, E. and Biswas, S. K. (2015) Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-$1{\alpha}$. Immunity 42, 484-498. https://doi.org/10.1016/j.immuni.2015.02.001
  95. Sharpe, A. H., Wherry, E. J., Ahmed, R. and Freeman, G. J. (2007) The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8, 239-245. https://doi.org/10.1038/ni1443
  96. Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J. D., Coopersmith, C. M., Hotchkiss, R. S., Levy, M. M., Marshall, J. C., Martin, G. S., Opal, S. M., Rubenfeld, G. D., van der Poll, T., Vincent, J. L. and Angus, D. C. (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3) JAMA 315, 801-810. https://doi.org/10.1001/jama.2016.0287
  97. Steinman, R. M. and Hemmi, H. (2006) Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311, 17-58.
  98. Stephan, F., Yang, K., Tankovic, J., Soussy, C. J., Dhonneur, G., Duvaldestin, P., Brochard, L., Brun-Buisson, C., Harf, A. and Delclaux, C. (2002) Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients. Crit. Care Med. 30, 315-322. https://doi.org/10.1097/00003246-200202000-00009
  99. Tamayo, E., Gomez, E., Bustamante, J., Gomez-Herreras, J. I., Fonteriz, R., Bobillo, F., Bermejo-Martin, J. F., Castrodeza, J., Heredia, M., Fierro, I. and Alvarez, F. J. (2012) Evolution of neutrophil apoptosis in septic shock survivors and nonsurvivors. J. Crit. Care 27, 415.e1-415.e11. https://doi.org/10.1016/j.jcrc.2011.09.001
  100. Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., Zheng, L., Gardet, A., Tong, Z., Jany, S. S., Corr, S. C., Haneklaus, M., Caffrey, B. E., Pierce, K., Walmsley, S., Beasley, F. C., Cummins, E., Nizet, V., Whyte, M., Taylor, C. T., Lin, H., Masters, S. L., Gottlieb, E., Kelly, V. P., Clish, C., Auron, P. E., Xavier, R. J. and O'Neill, L. A. (2013) Succinate is an inflammatory signal that induces IL-$1{\beta}$ through HIF-$1{\alpha}$. Nature 496, 238-242. https://doi.org/10.1038/nature11986
  101. Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., Leming, P. D., Spigel, D. R., Antonia, S. J., Horn, L., Drake, C. G., Pardoll, D. M., Chen, L., Sharfman, W. H., Anders, R. A., Taube, J. M., McMiller, T. L., Xu, H., Korman, A. J., Jure-Kunkel, M., Agrawal, S., McDonald, D., Kollia, G. D., Gupta, A., Wigginton, J. M. and Sznol, M. (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443-2454. https://doi.org/10.1056/NEJMoa1200690
  102. Torgersen, C., Moser, P., Luckner, G., Mayr, V., Jochberger, S., Hasibeder, W. R. and Dunser, M. W. (2009) Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth. Analg. 108, 1841-1847. https://doi.org/10.1213/ane.0b013e318195e11d
  103. Toti, P., De Felice, C., Occhini, R., Schuerfeld, K., Stumpo, M., Epistolato, M. C., Vatti, R. and Buonocore, G. (2004) Spleen depletion in neonatal sepsis and chorioamnionitis. Am. J. Clin. Pathol. 122, 765-771. https://doi.org/10.1309/RV6E9BMC9954A2WU
  104. Unsinger, J., Burnham, C. A., McDonough, J., Morre, M., Prakash, P. S., Caldwell, C. C., Dunne, W. M., Jr. and Hotchkiss, R. S. (2012) Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis. J. Infect. Dis. 206, 606-616. https://doi.org/10.1093/infdis/jis383
  105. Unsinger, J., McGlynn, M., Kasten, K. R., Hoekzema, A. S., Watanabe, E., Muenzer, J. T., McDonough, J. S., Tschoep, J., Ferguson, T. A., McDunn, J. E., Morre, M., Hildeman, D. A., Caldwell, C. C. and Hotchkiss, R. S. (2010) IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J. Immunol. 184, 3768-3779. https://doi.org/10.4049/jimmunol.0903151
  106. van de Veerdonk, F. L., Mouktaroudi, M., Ramakers, B. P., Pistiki, A., Pickkers, P., van der Meer, J. W., Netea, M. G. and Giamarellos-Bourboulis, E. J. (2012) Deficient Candida-specific T-helper 17 response during sepsis. J. Infect. Dis. 206, 1798-1802. https://doi.org/10.1093/infdis/jis596
  107. van Deuren, M., Frieling, J. T., van der Ven-Jongekrijg, J., Neeleman, C., Russel, F. G., van Lier, H. J., Bartelink, A. K. and van der Meer, J. W. (1998) Plasma patterns of tumor necrosis factor-${\alpha}$ (TNF) and TNF soluble receptors during acute meningococcal infections and the effect of plasma exchange. Clin. Infect. Dis. 26, 918-923. https://doi.org/10.1086/513933
  108. Venet, F., Chung, C. S., Kherouf, H., Geeraert, A., Malcus, C., Poitevin, F., Bohe, J., Lepape, A., Ayala, A. and Monneret, G. (2009) Increased circulating regulatory T cells (CD4+CD25+CD127-) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med. 35, 678-686. https://doi.org/10.1007/s00134-008-1337-8
  109. Venet, F., Davin, F., Guignant, C., Larue, A., Cazalis, M. A., Darbon, R., Allombert, C., Mougin, B., Malcus, C., Poitevin-Later, F., Lepape, A. and Monneret, G. (2010) Early assessment of leukocyte alterations at diagnosis of septic shock. Shock 34, 358-363. https://doi.org/10.1097/SHK.0b013e3181dc0977
  110. Venet, F., Foray, A. P., Villars-Mechin, A., Malcus, C., Poitevin-Later, F., Lepape, A. and Monneret, G. (2012) IL-7 restores lymphocyte functions in septic patients. J. Immunol. 189, 5073-5081. https://doi.org/10.4049/jimmunol.1202062
  111. Venet, F., Lukaszewicz, A. C., Payen, D., Hotchkiss, R. and Monneret, G. (2013) Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr. Opin. Immunol. 25, 477-483. https://doi.org/10.1016/j.coi.2013.05.006
  112. Venet, F., Pachot, A., Debard, A. L., Bohe, J., Bienvenu, J., Lepape, A. and Monneret, G. (2004) Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes. Crit. Care Med. 32, 2329-2331. https://doi.org/10.1097/01.CCM.0000145999.42971.4B
  113. Ward, P. A. and Bosmann, M. (2012) A historical perspective on sepsis. Am. J. Pathol. 181, 2-7. https://doi.org/10.1016/j.ajpath.2012.05.003
  114. Wick, M., Kollig, E., Muhr, G. and Koller, M. (2000) The potential pattern of circulating lymphocytes TH1/TH2 is not altered after multiple injuries. Arch. Surg. 135, 1309-1314. https://doi.org/10.1001/archsurg.135.11.1309
  115. Williams, S. C. (2012) After Xigris, researchers look to new targets to combat sepsis. Nat. Med. 18, 1001. https://doi.org/10.1038/nm0712-1001
  116. Winters, B. D., Eberlein, M., Leung, J., Needham, D. M., Pronovost, P. J. and Sevransky, J. E. (2010) Long-term mortality and quality of life in sepsis: a systematic review. Crit. Care Med. 38, 1276-1283. https://doi.org/10.1097/CCM.0b013e3181d8cc1d
  117. Wynn, J. L., Scumpia, P. O., Delano, M. J., O'Malley, K. A., Ungaro, R., Abouhamze, A. and Moldawer, L. L. (2007) Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock 28, 675-683.
  118. Xiao, W. Z., Mindrinos, M. N., Seok, J., Cuschieri, J., Cuenca, A. G., Gao, H., Hayden, D. L., Hennessy, L., Moore, E. E., Minei, J. P., Bankey, P. E., Johnson, J. L., Sperry, J., Nathens, A. B., Billiar, T. R., West, M. A., Brownstein, B. H., Mason, P. H., Baker, H. V., Finnerty, C. C., Jeschke, M. G., Lopez, M. C., Klein, M. B., Gamelli, R. L., Gibran, N. S., Arnoldo, B., Xu, W. H., Zhang, Y. P., Calvano, S. E., McDonald-Smith, G. P., Schoenfeld, D. A., Storey, J. D., Cobb, J. P., Warren, H. S., Moldawer, L. L., Herndon, D. N., Lowry, S. F., Maier, R. V., Davis, R. W. and Tompkins, R. G. (2011) A genomic storm in critically injured humans. J. Exp. Med. 208, 2581-2590. https://doi.org/10.1084/jem.20111354
  119. Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D. and Ahmed, R. (1998) Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188, 2205-2213. https://doi.org/10.1084/jem.188.12.2205
  120. Zhang, Y., Li, J., Lou, J., Zhou, Y., Bo, L., Zhu, J., Zhu, K., Wan, X., Cai, Z. and Deng, X. (2011) Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Crit. Care 15, R70. https://doi.org/10.1186/cc10059
  121. Zhang, Y., Zhou, Y., Lou, J., Li, J., Bo, L., Zhu, K., Wan, X., Deng, X. and Cai, Z. (2010) PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit. Care 14, R220. https://doi.org/10.1186/cc9354
  122. Ziegler, E. J., McCutchan, J. A., Fierer, J., Glauser, M. P., Sadoff, J. C., Douglas, H. and Braude, A. I. (1982) Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N. Engl. J. Med. 307, 1225-1230. https://doi.org/10.1056/NEJM198211113072001

Cited by

  1. Azithromycin in Combination with Ceftriaxone Reduces Systemic Inflammation and Provides Survival Benefit in a Murine Model of Polymicrobial Sepsis vol.62, pp.9, 2018, https://doi.org/10.1128/AAC.00752-18
  2. AWRK6, A Synthetic Cationic Peptide Derived from Antimicrobial Peptide Dybowskin-2CDYa, Inhibits Lipopolysaccharide-Induced Inflammatory Response vol.19, pp.2, 2018, https://doi.org/10.3390/ijms19020600
  3. Histone Deacetylation Inhibitors as Therapy Concept in Sepsis vol.20, pp.2, 2019, https://doi.org/10.3390/ijms20020346
  4. Analysis of the Expression and Regulation of PD-1 Protein on the Surface of Myeloid-Derived Suppressor Cells (MDSCs) vol.27, pp.1, 2017, https://doi.org/10.4062/biomolther.2018.201
  5. Switch of NAD Salvage to de novo Biosynthesis Sustains SIRT1-RelB-Dependent Inflammatory Tolerance vol.10, pp.None, 2019, https://doi.org/10.3389/fimmu.2019.02358
  6. Mouse Models of Sepsis and Septic Shock vol.53, pp.5, 2017, https://doi.org/10.1134/s0026893319050108
  7. Meta-tyrosine modulates the immune response induced by bacterial endotoxins vol.225, pp.1, 2017, https://doi.org/10.1016/j.imbio.2019.10.005